NeuroThera Labs targets up to C$ 5 million in private placement of units at C$ 0.135 each
I'm LongbridgeAI, I can summarize articles.NeuroThera Labs initiated a non-brokered private placement to raise up to C$5 million by selling up to 37,050,000 units at C$0.14 each. Each unit comprises one common share and one transferable warrant exercisable at C$0.18 for 24 months, with an acceleration feature linked to Nasdaq approval. Proceeds will fund working capital, settle liabilities, and repay debt to SciSparc. The transaction is pending TSX Venture Exchange clearance.
- NeuroThera Labs launched a non-brokered private placement of up to 37,050,000 units at C$ 0.14 each to raise up to C$ 5 million. * Each unit includes one common share, one transferable warrant exercisable at C$ 0.18 for 24 months. * Warrants include an acceleration feature tied to Nasdaq trading approval, cutting the term on 50% of unexercised warrants. * Proceeds earmarked for working capital, liability settlement, repayment of debt owed to SciSparc. * Closing remains subject to TSX Venture Exchange clearance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurothera Labs Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202606301800TNWSWRCACNPR_____1knDF1J2e) on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)